Available in 10 markets
iShares MSCI World Health Care Sector Advanced UCITS ETF
iShares MSCI World Health Care Sector Advanced UCITS ETF is an exchange-traded fund (ETF) from iShares, traded under the ticker WHCA (ISIN IE0009QS7W62). One trade buys a whole basket of holdings, so your money is spread out instead of riding on a single company. At its core it is a focused, thematic fund: it concentrates on the health care part…
Opens the screener with this filter applied.
About this fund
What you own
The MSCI World index is the benchmark this fund aims to copy. By holding it, this fund gives you a stake in around 127 companies across Global in a single purchase.
Dividends
The fund automatically reinvests dividends back into itself, so your holding grows without cash payouts.
Read more
Rolling the dividends straight back in means your money compounds automatically, with nothing for you to reinvest by hand. The flip side is there is no cash income; the growth simply shows up as a higher fund value. Note that reinvested dividends can still be taxable in some countries even though you never receive the cash — the rules depend on where you live.
How it works
The fund actually buys every share in the index it tracks (full replication).
Read more
Owning every holding keeps things transparent — what is in the index is what the fund actually owns. It can be a touch costlier to run for indexes with thousands of tiny positions, since the fund has to buy and maintain them all. There is no swap bank involved, so there is no extra “what if the partner fails” question to weigh.
Cost
The yearly running cost of the fund, shown as a % of your money. Lower is cheaper.
Read more
For example, a 0.20% fee works out at €0.20 a year for every €100 invested — that’s a generic illustration of the mechanic, not this fund’s own fee. It is skimmed quietly from inside the fund a little each day, so you never get a bill — but it drags on your return every year you hold. On a broad index ETF it is usually a small fraction of a percent; the gap between a cheap and a pricey fund looks tiny on day one but compounds over decades, which is why it is worth a glance.
Fund facts
Performance
Growth of $100 invested — the line starts at $100.
End-of-day prices, rebased to a common start so the shapes are comparable. Past performance does not predict future results.
Return, year by year
How bumpy has it been?
The bigger picture
What's inside
By sector ?
The 10 biggest holdings make up 46.7% of the fund — the rest is spread across roughly 117 more companies.
Top 10 holdings
| # | Company | Weight |
|---|---|---|
| 1 | ELI LILLY | 11.3% |
| 2 | JOHNSON & JOHNSON | 6.0% |
| 3 | ABBVIE INC | 5.6% |
| 4 | NOVARTIS AG | 5.3% |
| 5 | UNITEDHEALTH GROUP INC | 4.2% |
| 6 | ROCHE PS PAR AG | 3.4% |
| 7 | MERCK & CO INC | 3.3% |
| 8 | ASTRAZENECA PLC | 3.3% |
| 9 | GILEAD SCIENCES INC | 2.3% |
| 10 | AMGEN INC | 2.1% |
Where to buy this fund
Set from your language & location — change it if it's wrong.
Where it trades
| Exchange | Ticker | Currency | |
|---|---|---|---|
| LSE | WHCA | USD | ★ Primary |
| CHF listings | |||
| SIX | WHCA | CHF | |
| EUR listings | |||
| Euronext Amsterdam | WHCA | EUR | |
| Frankfurt | CBUR | EUR | |
| USD listings | |||
| B3 | WHCAA | USD | |
| B3 | WHCAL | USD | |
| B3 | WHCAZ | USD | |
| E1 | WHCAEUR | USD | |
| E1 | WHCAGBP | USD | |
| E1 | WHCAUSD | USD | |
| EB | WHCAZ | USD | |
| EB | WHCAA | USD | |
| EO | WHCAGBP | USD | |
| EO | WHCAUSD | USD | |
| EP | WHCAEUR | USD | |
| EP | WHCAUSD | USD | |
| EU | WHCAUSD | USD | |
| EU | WHCAGBP | USD | |
| EU | WHCAEUR | USD | |
| EZ | WHCAEUR | USD | |
| EZ | WHCAUSD | USD | |
| GD | CBUR | USD | |
| GZ | CBUR | USD | |
| I2 | WHCAA | USD | |
| IX | WHCAA | USD | |
| IX | WHCAZ | USD | |
| L1 | WHCAZ | USD | |
| L1 | WHCAL | USD | |
| L1 | WHCAA | USD | |
| L3 | WHCAA | USD | |
| L3 | WHCAL | USD | |
| L3 | WHCAZ | USD | |
| LA | CBUR | USD | |
| London Stock Exchange | WHCA | USD | |
| LU | CBUR | USD | |
| PO | WHCAA | USD | |
| PO | WHCAL | USD | |
| PO | WHCAZ | USD | |
| QT | CBUR | USD | |
| S1 | WHCAA | USD | |
| S1 | WHCAZ | USD | |
| S2 | WHCAA | USD | |
| S4 | WHCAA | USD | |
| SE | WHCA | USD | |
| TH | CBUR | USD | |
| X1 | WHCAEUR | USD | |
| X1 | WHCAGBP | USD | |
| X1 | WHCAUSD | USD | |
| X2 | WHCAUSD | USD | |
| X2 | WHCAGBP | USD | |
| X2 | WHCAEUR | USD | |
| X9 | WHCAEUR | USD | |
| XA | WHCAEUR | USD | |
| XA | WHCAGBP | USD | |
| XA | WHCAUSD | USD | |
| XE | WHCAEUR | USD | |
| XF | WHCAEUR | USD | |
| XF | WHCAGBP | USD | |
| XF | WHCAUSD | USD | |
| XG | WHCAUSD | USD | |
| XG | WHCAGBP | USD | |
| XG | WHCAEUR | USD | |
| XH | WHCAEUR | USD | |
| XH | WHCAGBP | USD | |
| XH | WHCAUSD | USD | |
| XJ | WHCAUSD | USD | |
| XJ | WHCAGBP | USD | |
| XJ | WHCAEUR | USD | |
| XL | WHCAEUR | USD | |
| XL | WHCAGBP | USD | |
| XL | WHCAUSD | USD | |
| XO | WHCAUSD | USD | |
| XO | WHCAGBP | USD | |
| XO | WHCAEUR | USD | |
| XQ | WHCAEUR | USD | |
| XQ | WHCAGBP | USD | |
| XQ | WHCAUSD | USD | |
| XS | WHCAEUR | USD | |
| XT | WHCAUSD | USD | |
| XT | WHCAGBP | USD | |
| XU | WHCAEUR | USD | |
| XU | WHCAGBP | USD | |
| XU | WHCAUSD | USD | |
| XV | WHCAUSD | USD | |
| XV | WHCAGBP | USD | |
| XV | WHCAEUR | USD | |
| XW | WHCAEUR | USD | |
| XW | WHCAGBP | USD | |
| XW | WHCAUSD | USD | |
| XX | WHCAUSD | USD | |
| XX | WHCAGBP | USD | |
| XX | WHCAEUR | USD | |
| XY | WHCAGBP | USD | |
| XY | WHCAUSD | USD | |
| XZ | WHCAEUR | USD | |
| XZ | WHCAGBP | USD | |
| XZ | WHCAUSD | USD | |
For serious comparison — full data holdings, percentiles, advanced risk, tilt, flows
Full holdings
As of 2026-07-24 · the fund's own published holdings.
| # | Company | Weight |
|---|---|---|
| 1 | ELI LILLY | 11.3% |
| 2 | JOHNSON & JOHNSON | 6.0% |
| 3 | ABBVIE INC | 5.6% |
| 4 | NOVARTIS AG | 5.3% |
| 5 | UNITEDHEALTH GROUP INC | 4.2% |
| 6 | ROCHE PS PAR AG | 3.4% |
| 7 | MERCK & CO INC | 3.3% |
| 8 | ASTRAZENECA PLC | 3.3% |
| 9 | GILEAD SCIENCES INC | 2.3% |
| 10 | AMGEN INC | 2.1% |
| 11 | STRYKER CORP | 1.9% |
| 12 | NOVO NORDISK CLASS B | 1.8% |
| 13 | VERTEX PHARMACEUTICALS INC | 1.8% |
| 14 | CARDINAL HEALTH INC | 1.8% |
| 15 | MCKESSON CORP | 1.7% |
| 16 | CENCORA INC | 1.6% |
| 17 | IDEXX LABORATORIES INC | 1.6% |
| 18 | METTLER TOLEDO INC | 1.6% |
| 19 | SANOFI SA | 1.6% |
| 20 | ELEVANCE HEALTH INC | 1.5% |
| 21 | CIGNA | 1.4% |
| 22 | THERMO FISHER SCIENTIFIC INC | 1.4% |
| 23 | EDWARDS LIFESCIENCES CORP | 1.3% |
| 24 | ALCON AG | 1.3% |
| 25 | GLAXOSMITHKLINE | 1.2% |
| 26 | PFIZER INC | 1.2% |
| 27 | BRISTOL MYERS SQUIBB | 1.1% |
| 28 | TAKEDA PHARMACEUTICAL LTD | 1.1% |
| 29 | ZOETIS INC CLASS A | 1.1% |
| 30 | DANAHER CORP | 1.1% |
| 31 | STERIS | 1.1% |
| 32 | INTUITIVE SURGICAL INC | 1.0% |
| 33 | IQVIA HOLDINGS INC | 1.0% |
| 34 | VEEVA SYSTEMS INC CLASS A | 1.0% |
| 35 | HUMANA INC | 0.9% |
| 36 | UCB SA | 0.8% |
| 37 | WATERS CORP | 0.8% |
| 38 | SONOVA HOLDING AG | 0.8% |
| 39 | STRAUMANN HOLDING AG | 0.7% |
| 40 | HALEON PLC | 0.7% |
| 41 | ALNYLAM PHARMACEUTICALS INC | 0.6% |
| 42 | ASTELLAS PHARMA INC | 0.6% |
| 43 | DAIICHI SANKYO LTD | 0.6% |
| 44 | CVS HEALTH CORP | 0.6% |
| 45 | SIGMA HEALTHCARE LTD | 0.6% |
| 46 | ROYALTY PHARMA PLC CLASS A | 0.6% |
| 47 | GALDERMA GROUP N AG | 0.6% |
| 48 | ABBOTT LABORATORIES | 0.5% |
| 49 | QIAGEN NV | 0.5% |
| 50 | INCYTE CORP | 0.5% |
| 51 | CENTENE CORP | 0.4% |
| 52 | AGILENT TECHNOLOGIES INC | 0.4% |
| 53 | ARGENX | 0.4% |
| 54 | CHUGAI PHARMACEUTICAL LTD | 0.4% |
| 55 | RESMED INC | 0.4% |
| 56 | ROCHE HOLDING AG | 0.4% |
| 57 | BIOGEN INC | 0.4% |
| 58 | COCHLEAR LTD | 0.4% |
| 59 | EISAI LTD | 0.4% |
| 60 | MERCK | 0.3% |
| 61 | MEDTRONIC PLC | 0.3% |
| 62 | SONIC HEALTHCARE LTD | 0.3% |
| 63 | REGENERON PHARMACEUTICALS INC | 0.3% |
| 64 | ESSILORLUXOTTICA SA | 0.3% |
| 65 | IPSEN SA | 0.3% |
| 66 | COLOPLAST B | 0.3% |
| 67 | WEST PHARMACEUTICAL SERVICES INC | 0.3% |
| 68 | USD CASH | 0.2% |
| 69 | HCA HEALTHCARE INC | 0.2% |
| 70 | BOSTON SCIENTIFIC CORP | 0.2% |
| 71 | GENMAB | 0.2% |
| 72 | BAYER AG | 0.2% |
| 73 | SWEDISH ORPHAN BIOVITRUM | 0.2% |
| 74 | HOYA CORP | 0.2% |
| 75 | LABCORP HOLDINGS INC | 0.2% |
| 76 | LONZA GROUP AG | 0.2% |
| 77 | SMITH AND NEPHEW PLC | 0.2% |
| 78 | BECTON DICKINSON | 0.1% |
| 79 | INSMED INC | 0.1% |
| 80 | CSL LTD | 0.1% |
| 81 | TEVA PHARMACEUTICAL INDUSTRIES ADR | 0.1% |
| 82 | NATERA INC | 0.1% |
| 83 | SANDOZ GROUP AG | 0.1% |
| 84 | SHIONOGI LTD | 0.1% |
| 85 | REVOLUTION MEDICINES INC | 0.1% |
| 86 | OTSUKA HOLDINGS LTD | 0.1% |
| 87 | ILLUMINA INC | 0.1% |
| 88 | GE HEALTHCARE TECHNOLOGIES INC | 0.1% |
| 89 | DEXCOM INC | 0.1% |
| 90 | QUEST DIAGNOSTICS INC | 0.1% |
| 91 | KONINKLIJKE PHILIPS NV | 0.1% |
| 92 | UNITED THERAPEUTICS CORP | 0.1% |
| 93 | FRESENIUS SE AND CO KGAA | 0.1% |
| 94 | PRO MEDICUS LTD | 0.1% |
| 95 | TERUMO CORP | 0.1% |
| 96 | ORION CLASS B | 0.1% |
| 97 | NEUROCRINE BIOSCIENCES INC | 0.1% |
| 98 | ZIMMER BIOMET HOLDINGS INC | 0.1% |
| 99 | DEMANT | 0.0% |
| 100 | COOPER INC | 0.0% |
| 101 | SIEMENS HEALTHINEERS AG | 0.0% |
| 102 | SARTORIUS STEDIM BIOTECH SA | 0.0% |
| 103 | KYOWA KIRIN LTD | 0.0% |
| 104 | EUROFINS SCIENTIFIC | 0.0% |
| 105 | FINANCIERE DE TUBIZE SA | 0.0% |
| 106 | FISHER AND PAYKEL HEALTHCARE CORPO | 0.0% |
| 107 | FRESENIUS MEDICAL CARE AG | 0.0% |
| 108 | INSULET CORP | 0.0% |
| 109 | SARTORIUS PREF AG | 0.0% |
| 110 | BIOMERIEUX SA | 0.0% |
| 111 | EUR CASH | 0.0% |
| 112 | RECORDATI INDUSTRIA CHIMICA E FARM | 0.0% |
| 113 | OLYMPUS CORP | 0.0% |
| 114 | JPY CASH | 0.0% |
| 115 | GBP CASH | 0.0% |
| 116 | CASH COLLATERAL USD HSBFT | 0.0% |
| 117 | CHF CASH | 0.0% |
| 118 | CASH COLLATERAL EUR HSBFT | 0.0% |
| 119 | AUD CASH | 0.0% |
| 120 | NZD CASH | 0.0% |
| 121 | SEK CASH | 0.0% |
| 122 | DKK CASH | 0.0% |
| 123 | CAD CASH | 0.0% |
| 124 | HOLOGIC INC | 0.0% |
| 125 | HKD CASH | 0.0% |
| 126 | STOXX 600 HEALTH SEP 26 | 0.0% |
| 127 | E-MINI HEALTH CARE SECTOR SEP 26 | 0.0% |
How it ranks vs peers
Versus the Equity (stocks) · Global · Health Care · USD ETFs we track.
Advanced risk
Concentration depth
Roughly 127 companies are held, but the largest names carry most of the weight — so it behaves like ~29 equal-sized positions.
Tilt vs a world tracker
Percentage points over / under a broad world-equity tracker (not a licensed benchmark).
Estimated fund flows
Estimated from fund-size changes.
Documents
Similar funds
We found 6 funds that do much the same job as this one. To pick them we matched this fund's asset class and region, then show how close each match is below.
| iShares MSCI World Health Care Sector Advanced UCITS ETFiSharesYou're viewing | iShares Core MSCI World UCITS ETFiSharesSame index | iShares Core MSCI World UCITS ETFiSharesSame index | iShares Core MSCI World UCITS ETFiSharesSame index | iShares Core MSCI World UCITS ETFiSharesSame index | State Street® SPDR® Portfolio Developed World ex-US ETFSPDRBroader match | iShares MSCI ACWI UCITS ETFiSharesBroader match | |
|---|---|---|---|---|---|---|---|
| Why it's similar | This is the fund on this page. | Same indexPhysical | Same indexPhysical | Same indexPhysical | Same indexAccumulatingPhysical | StocksPhysicalCheaper fee Tracks a different index in the same category. | StocksPhysical Tracks a different index in the same category. |
| Index tracked | MSCI World | MSCI World | MSCI World | MSCI World | MSCI World | S&P Developed Ex-U.S. BMI Index | MSCI ACWI |
| Yearly fee (TER) | 0.18% | 0.30% | 0.30% | 0.20% | 0.20% | 0.03% | 0.20% |
| All-in cost | 0.18% | 0.30% | 0.00% | 0.00% | 0.20% | 0.00% | 0.00% |
| Fund size | €832.5M | €166B | €146.5B | €128.1B | €127.6B | €35.6B | €30.7B |
| Domicile | Ireland | Ireland | Ireland | Ireland | Ireland | United States | Ireland |
| Replication | Physical (full) | Physical (full) | Physical (full) | Physical (full) | Physical (full) | Physical (full) | Physical (full) |
| 3-yr return p.a. | +4.7% | +16.8% | +17.8% | +18.3% | +17.8% | ||
| 5-yr return p.a. | +9.7% | +9.3% | +11.3% | +7.1% | |||
| # holdings | 127 | 1,356 | 1,356 | 1,356 | 1,356 | 2,459 | 1,738 |
The fund on this page stays pinned on the left — scroll or use ‹ › to compare it against each one.
Open the full comparison tool →New to ETFs? Start with the basics →
Finance Hamster provides educational information about ETFs and investing. It is not investment, tax, or legal advice, and not a recommendation to buy or sell any security. Markets carry risk; do your own research or consult a licensed adviser.